| Literature DB >> 26173643 |
Viviana Cordeddu1,2, Jiani C Yin3, Cecilia Gunnarsson4, Carl Virtanen3, Séverine Drunat5, Francesca Lepri6, Alessandro De Luca7, Cesare Rossi8, Andrea Ciolfi1, Trevor J Pugh3, Alessandro Bruselles1, James R Priest9,10, Len A Pennacchio11,12, Zhibin Lu3, Arnavaz Danesh3, Rene Quevedo3, Alaa Hamid3, Simone Martinelli1, Francesca Pantaleoni1, Maria Gnazzo6, Paola Daniele7, Christina Lissewski13, Gianfranco Bocchinfuso14, Lorenzo Stella14, Sylvie Odent15, Nicole Philip16, Laurence Faivre17, Marketa Vlckova18, Eva Seemanova18, Cristina Digilio6, Martin Zenker13, Giuseppe Zampino19, Alain Verloes5, Bruno Dallapiccola6, Amy E Roberts20, Hélène Cavé5,21, Bruce D Gelb22, Benjamin G Neel3,23, Marco Tartaglia1,6.
Abstract
The RASopathies constitute a family of autosomal-dominant disorders whose major features include facial dysmorphism, cardiac defects, reduced postnatal growth, variable cognitive deficits, ectodermal and skeletal anomalies, and susceptibility to certain malignancies. Noonan syndrome (NS), the commonest RASopathy, is genetically heterogeneous and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (ERK) signal transduction pathway. Mutations in known disease genes account for approximately 80% of affected individuals. Here, we report that missense mutations altering Son of Sevenless, Drosophila, homolog 2 (SOS2), which encodes a RAS guanine nucleotide exchange factor, occur in a small percentage of subjects with NS. Four missense mutations were identified in five unrelated sporadic cases and families transmitting NS. Disease-causing mutations affected three conserved residues located in the Dbl homology (DH) domain, of which two are directly involved in the intramolecular binding network maintaining SOS2 in its autoinhibited conformation. All mutations were found to promote enhanced signaling from RAS to ERK. Similar to NS-causing SOS1 mutations, the phenotype associated with SOS2 defects is characterized by normal development and growth, as well as marked ectodermal involvement. Unlike SOS1 mutations, however, those in SOS2 are restricted to the DH domain.Entities:
Keywords: Noonan syndrome; RAS signaling; SOS2; genotype-phenotype correlations
Mesh:
Substances:
Year: 2015 PMID: 26173643 PMCID: PMC4604019 DOI: 10.1002/humu.22834
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878